Cypher AI, a company focused on AI-driven digital infrastructure for life sciences R&D, has successfully secured $2 million in Seed funding.
This funding round was led by MaC Venture Capital, with contributions from several investors including Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures. The capital will be directed towards enhancing the company's operations and advancing its development projects.
Founded in 2025 by Yaoyu Yang, Cypher AI aims to transform the biotech research landscape by providing a comprehensive operating layer service. This service seeks to replace outdated, fragmented manual systems with an integrated platform that unifies experiment design, execution, analysis, and vendor coordination.
By collaborating with biotech, pharmaceutical, and research organizations, Cypher AI is positioned to accelerate innovation and discovery within the life sciences sector. The funding marks a significant step in the company's mission to streamline research processes and improve efficiency in drug development.